Close Menu

NEW YORK (360Dx) — Bluejay Diagnostics said today that it has received a CE mark for its Allereye Tear Total IgE point-of-care test for the diagnosis of allergic conjunctivitis.

Allereye comprises a reagent-ready test strip that measures the presence of human immunoglobulin E (IgE) in a tear sample within 10 minutes. Acton, Massachusetts-based Bluejay said it expects to launch the test in Europe and the Middle East in the second quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

With COVID-19 vaccines rolling out, clinical labs and test developers are preparing for changes in both demand for testing and types of testing for SARS-CoV-2.

Sponsored by

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.